This week, the European Commission granted marketing authorization to the expanded use of AbbVie’s ABBV Rinvoq and ...

Nuclear energy's role in reducing carbon emissions and high efficiency makes it a significant player in the clean energy ...

Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...

UBS analyst Matthew Weston maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p14,200.00. The ...

AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...

AstraZeneca Pharmaceuticals LP and a Christian sales specialist have agreed to settle his suit over the company’s failure to ...

AstraZeneca PLC closed 27.79% below its 52-week high of £133.88, which the company achieved on September 3rd.

With its ability to specifically inhibit the mutant IDH1 enzyme, TIBSOVO addresses an unmet need in personalized cancer treatment, offering new hope for patients with limited options. As clinical ...

One bright spot for Chancellor Rachel Reeves is the fact the British economy is 75% services – left untouched by the tariffs ...

The PGIM Jennison Rising Dividend Fund declined for Q4 2024 and underperformed the 2.4% return of the S&P 500 Index. Click ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...